COGENT BIOSCIENCES INC
COGT · NASDAQ
Updated at 2026-10-13 14:20:22
- Today's High
- $29.48
- Today’s Low
- $28.36
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $30.81
- Previous Close
- $29.78
- Volume
- 1.85M
- Market Cap
- $5.16B
- P/E Ratio
- --
- EPS
- $-2.43
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 180 THIRD AVENUE, WALTHAM, MA, UNITED STATES, 02451
- Country
- US
- Listing Date
- 2018-03-29
- Fiscal Year End
- December
- Shares Outstanding
- 170.87M
- CIK
- 0001622229
- Website
- www.cogentbio.com
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$102.63M
2026-03-31
$102.45M
2025-12-31
$98.31M
2025-09-30
$83.35M
Net Income
2026-06-30
-$96.4M
2026-03-31
-$97.35M
2025-12-31
-$102.49M
2025-09-30
-$80.93M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.52
2026-03-31
$-0.53
2025-12-31
$-0.56
2025-09-30
$-0.50
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$94.44M
2026-03-31
-$94.98M
2025-12-31
-$104.6M
2025-09-30
-$78.32M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $102.63M | $102.45M | $98.31M | $83.35M |
| Net Income | -$96.4M | -$97.35M | -$102.49M | -$80.93M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.52 | $-0.53 | $-0.56 | $-0.50 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$94.44M | -$94.98M | -$104.6M | -$78.32M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.